September 15th, 2020 | 8:30 am – 12:30 pm

IMODE is organising its sixth annual convention during MedFIT with a morning conference on September 15th. IMODE will also hold an exhibition stand during MedFIT convention and participate to MedFIT one-to-one meetings.

PROGRAMME | September 15th 

8.30 – 9.00 AM
Name badge pickup and Welcome coffee – MedFIT


9.00 AM – 10.30 AM

10.30 AM – 11.00 AM
Networking break – MedFIT


11.00 AM – 11.30 AM


12.30 AM – 2.00 PM
Lunch – MedFIT


1.00 PM – 6.00 PM
Access to MedFIT and one-to-one meetings


– Prof. Dennis Douroumis, University of Greenwich, Faculty of Engineering and Science 

– Dr. Sheng Qi, University of East Anglia 

– Dr. Nicolas Blanchemain, University of Lille

– Dr. Rima Ait-Belkacem, Imabiotech

– Dr. Tina Vermonden, University of Utrecht

“Hyaluronic acid hydrogels: from protein delivery to 3D bioprinting.”


  • Registration to IMODE convention is free but mandatory, it gives you a free access for the afternoon of the 15th of September to MedFIT.
  • By participating to IMODE convention, you may obtain a 50% discount on your MedFIT pass for the second day, the 16th of September. Please contact Ségolène Lebrun to obtain your coupon code.
  • If you are already registered for MedFIT, the access to IMODE Convention is free.

About IMODE 

IMODE is a collaborative research project for multicomponent pharmaceutical products (co-amorphous and co-crystals) and medical devices that are loaded with bioactive molecules. Started in 2016, the IMODE project is funded by the European Interreg 2 Seas programme and co-financed by the European Regional Development Fund (ERDF).

The project’s overall objective is to bring together the specific transdisciplinary skills and experiences of partners (academic research groups, development agencies, SMEs) in order to provide the 2 Seas Area with strategic advantages for innovative pharmaceutical and medical applications. The IMODE project is motivated by an unmet need to develop solutions to addressing societal challenges to improve healthcare and provide novel and effective medication for various cardiovascular or gastro-intestinal conditions that lack or have inadequate treatment, all while keeping medical costs low.

More information about IMODE:

IMODE partners: